written by reader Agora’s Latest – “Agora Financial’s FDA Trader”

By highlands, July 24, 2015

Agora is claiming a ”flaw” in the stock market via the ”PDUFA” (an acronym that originated with the Prescription Drug User Fee Act) that allows them to know in advance a ”magic” date that the FDA will reveal critical information about a certain drug’s approval or disapproval status. To quote Agora, ”during the review process of a new drug, the FDA will often “tip their hand” to certain investors — and reveal the exact day when the FDA plans to announce whether or not a drug has been approved…”. All you have to do is get your trade in before that date then await the windfall.
November 11, 2015 is the latest date being touted. Very tempted to give them my hard earned $1500 for a 12 month subscription but don’t want to get disappointed.
Anyone involved this that will admit to it? It’s TOP SECRET per Agora.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

Share your thoughts...

1 Comment threads
0 Thread replies
Most reacted comment
Hottest comment thread
1 Comment authors
Pat Brady Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.


I’d like to know more about those “magic dates” too, especially since Nov. 11 is coming fast. However, just because the FDA is posting info regarding a new drug, it could just as easily announce that it needs more testing and is NOT approved. How can we tell beforehand if the drug is a winner or a loser? I’m not sure Agora actually makes that clear.

Add a Topic
Add a Topic